Literature DB >> 31128232

The prevalence and persistence of atopic dermatitis in urban United States children.

Costner McKenzie1, Jonathan I Silverberg2.   

Abstract

BACKGROUND: Previous studies found that childhood atopic dermatitis (AD) and asthma are associated with residence in urban areas. However, little is known about the prevalence and determinants of AD in US urban populations and its impact on quality-of-life (QOL) and asthma.
OBJECTIVE: To determine AD prevalence and persistence, sociodemographic predictors thereof, and association with QOL and atopic comorbidities in US urban children.
METHODS: We analyzed data from The Fragile Families and Child Wellbeing Study, a prospective cohort study of 4898 women and their children born in 20 large US cities between 1998 and 2000. AD prevalence was determined at ages 5, 9, and 15 years, and stratified by sex, race/ethnicity, and household poverty income level.
RESULTS: The prevalences (95% confidence interval [CI]) of childhood AD were 15.0% (11.0%-18.9%), 15.1% (11.5%-18.7%), and 14.5% (10.4%%-18.5%) at ages 5, 9, and 15 years, respectively. Female sex (multivariable repeated measures logistic regression; adjusted odds-ratio [95% CI]: 1.56 [1.02-2.37]) and black race (1.80 [1.07-3.01]) were associated with persistent AD across all 3 ages. Children with AD at ages 5 and 15 (2.63 [1.42-4.86]), 5, 8 and 15 (1.47 [1.02-2.12]) and 9 and 15 years (1.61 [1.00-2.60]) had higher odds of poor/fair/good overall health. Children with AD at ages 5 and 9 years had the highest odds of ever having asthma (adjusted odds ratio [95% confidence interval]: 6.05 [5.88-6.22]), followed by children with AD at ages 5, 9, and 15 years (3.17 [3.07%-3.27]).
CONCLUSION: Atopic dermatitis prevalence and persistence were highest in US urban children who were female or black. Urban children with persistent AD were more likely to have poor QOL and asthma.
Copyright © 2019 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31128232     DOI: 10.1016/j.anai.2019.05.014

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  18 in total

Review 1.  Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice.

Authors:  Raj Chovatiya; Jonathan I Silverberg
Journal:  Am J Clin Dermatol       Date:  2022-05-31       Impact factor: 6.233

Review 2.  Structural racism and its pathways to asthma and atopic dermatitis.

Authors:  Adali Martinez; Rosemarie de la Rosa; Mahasin Mujahid; Neeta Thakur
Journal:  J Allergy Clin Immunol       Date:  2021-11       Impact factor: 14.290

3.  Network pharmacology and molecular docking-based prediction of active compounds and mechanisms of action of Cnidii Fructus in treating atopic dermatitis.

Authors:  Shakeel Ahmad Khan; Ying Wu; Amy Sze-Man Li; Xiu-Qiong Fu; Zhi-Ling Yu
Journal:  BMC Complement Med Ther       Date:  2022-10-19

4.  Infertility treatment associated with childhood asthma and atopy.

Authors:  Kristen J Polinski; Danielle R Stevens; Pauline Mendola; Tzu-Chun Lin; Rajeshwari Sundaram; Erin Bell; Edwina H Yeung
Journal:  Hum Reprod       Date:  2022-06-30       Impact factor: 6.353

5.  Mental Health Symptoms and Functional Impairment in Children With Atopic Dermatitis.

Authors:  Brian T Cheng; Anna B Fishbein; Jonathan Ian Silverberg
Journal:  Dermatitis       Date:  2021 Sep-Oct 01       Impact factor: 4.845

Review 6.  Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations.

Authors:  Emily A Croce; Moise L Levy; Adewole S Adamson; Elizabeth C Matsui
Journal:  J Allergy Clin Immunol       Date:  2021-09-30       Impact factor: 10.793

7.  Pathophysiology of Atopic Dermatitis and Psoriasis: Implications for Management in Children.

Authors:  Raj Chovatiya; Jonathan I Silverberg
Journal:  Children (Basel)       Date:  2019-10-04

8.  Antipruritic Effect of Ethyl Acetate Extract from Fructus cnidii in Mice with 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis.

Authors:  Xi Chen; Chan Zhu; Yingge Zhang; Niuniu Yang; Hao Shi; Weiwei Yang; Yan Yang; Jianqiang Liang; Liuzhi Chen; Xueying Zeng; Rijin Cai; Guanyi Wu; Zongxiang Tang
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-06       Impact factor: 2.629

Review 9.  Update on the Pathogenesis and Therapy of Atopic Dermatitis.

Authors:  Huaguo Li; Zhen Zhang; Hui Zhang; Yifeng Guo; Zhirong Yao
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-02       Impact factor: 8.667

Review 10.  Recent advances in atopic dermatitis.

Authors:  Kangmo Ahn; Byung Eui Kim; Jihyun Kim; Donald Ym Leung
Journal:  Curr Opin Immunol       Date:  2020-04-13       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.